Development of a doxorubicin resistance model in HER2- and HER2+ breast cancer to analyze potential therapy targets and drug delivery methods

Name: Development of a doxorubicin resistance model in HER2- and HER2+ breast cancer to analyze potential therapy targets and drug delivery methods
Creator: Poznan University of Medical Sciences
Published: 2026-03-20T12:33:48+08:00

RepOD Repository for Open Data2026-03-20 更新2026-07-23 收录

乳腺癌耐药性

药物递送机制

数据链接：

https://repod.icm.edu.pl/dataset.xhtml?persistentId=doi:10.18150/W0JPSL 数据链接链接失效反馈

官方服务：

资源简介：

Molenda, Sara, 2026, "Development of a doxorubicin resistance model in HER2- and HER2+ breast cancer to analyze potential therapy targets and drug delivery methods", https://doi.org/10.18150/W0JPSL, RepOD, V1

提供机构：

Poznan University of Medical Sciences

创建时间：

2026-03-20